[HTML][HTML] Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
1. Cooksley CD, Avritscher EBC, Bekele BN, et al. Epidemiology and outcomes of serious
influenza-related infections in the cancer population. Cancer. 2005; 104: 618e628. 2 …
influenza-related infections in the cancer population. Cancer. 2005; 104: 618e628. 2 …
[HTML][HTML] Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
Thehypoxia and profound inflammatory response associated with the pneumonitisobserved
with the SARS-CoV-2 virus responsible for the recent COVID-19 pandemic has …
with the SARS-CoV-2 virus responsible for the recent COVID-19 pandemic has …
[HTML][HTML] Commentary: SARS-CoV-2 vaccines and cancer patients
C Corti, G Curigliano - Annals of Oncology, 2021 - ncbi.nlm.nih.gov
Since the first reports of coronavirus disease 2019 (COVID-19), severe acute respiratory
syndrome coronavirus 2 (SARS-Cov-2) infection has affected more than 79 million people …
syndrome coronavirus 2 (SARS-Cov-2) infection has affected more than 79 million people …
A rapid fatal evolution of coronavirus disease-19 in a patient with advanced lung cancer with a long-time response to nivolumab
L Bonomi, L Ghilardi, E Arnoldi, CA Tondini… - Journal of Thoracic …, 2020 - jto.org
1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel
coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506. 2. Hu Z, Song C, Xu C, et al …
coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506. 2. Hu Z, Song C, Xu C, et al …
Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19
Importance Cytokine storm due to COVID-19 can cause high morbidity and mortality and
may be more common in patients with cancer treated with immunotherapy (IO) due to …
may be more common in patients with cancer treated with immunotherapy (IO) due to …
Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
ML Solodky, C Galvez, B Russias… - Annals of …, 2020 - annalsofoncology.org
1. Colloca G, Venturino A, Guarneri D. Neutropenia in metastatic colorectal cancer receiving
trifluridine/tipiracil. Ann Oncol. 2020; 31 (7): 958. 2. Yoshino T, Cleary JM, Van Cutsem E, et …
trifluridine/tipiracil. Ann Oncol. 2020; 31 (7): 958. 2. Yoshino T, Cleary JM, Van Cutsem E, et …
[HTML][HTML] COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Emerging efficacy data have led to the emergency use authorization or approval of COVID-
19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded …
19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded …
[HTML][HTML] COVID-19 and lung cancer: risks, mechanisms and treatment interactions
Cases of the 2019 novel coronavirus also known as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) continue to rise worldwide. To date, there is no effective …
coronavirus 2 (SARS-CoV-2) continue to rise worldwide. To date, there is no effective …
[HTML][HTML] COVID-19 infection in cancer patients: early observations and unanswered questions
WK Oh - Annals of Oncology, 2020 - annalsofoncology.org
The coronavirus disease 2019 (COVID-19) pandemic has no true precedent in modern
times and is a rapidly evolving crisis worldwide. Risk factors for severe outcomes and death …
times and is a rapidly evolving crisis worldwide. Risk factors for severe outcomes and death …
Active and effective measures for the care of patients with cancer during the COVID-19 spread in China
Z Wang, J Wang, J He - JAMA oncology, 2020 - jamanetwork.com
Recently, anoutbreakofthehighlyinfectiousnovelcoron… (COVID-19) hassweptWuhan,
China, with 80 303 confirmed diagnosed cases in China as of March 3, 2020. 1 Considering …
China, with 80 303 confirmed diagnosed cases in China as of March 3, 2020. 1 Considering …